Table 3 B19V IgG seropositivity in Australian blood donors, 2016
From: Seroprevalence of antibodies to primate erythroparvovirus 1 (B19V) in Australia
Variable | Number tested | B19V IgG seropositive | Univariate logistic regression analysis | Multivariate logistic regression analysis | |||
|---|---|---|---|---|---|---|---|
n | % (95% CI) | OR (95% CI) | P value | OR (95% CI) | P value | ||
TOTAL | 2221 | 1360 | 61.23 (59.21–63.26) | – | – | – | – |
Sex |  |  |  |  | – |  |  |
 Male | 1109 | 686 | 61.86 (59.00–64.72) | a | – | – | – |
 Female | 1112 | 674 | 60.61 (57.75–63.48) | 0.95 (0.80–1.13) | 0.547 | – | – |
Age group |  |  |  |  | < 0.001 |  | < 0.001 |
 16–24 | 374 | 192 | 51.34 (46.27–56.40) | a | – | a | – |
 25–34 | 376 | 221 | 58.78 (53.80–63.75) | 1.35 (1.01–1.80) | 0.041 | 1.36 (1.016–1.82) | 0.039 |
 35–44 | 376 | 202 | 53.72 (48.68–58.76) | 1.10 (0.83–1.47) | 0.513 | 1.10 (0.83–1.47) | 0.503 |
 45–54 | 376 | 235 | 62.50 (57.61–67.39) | 1.58 (1.18–2.11) | 0.002 | 1.59 (1.19–2.13) | 0.002 |
 55–64 | 367 | 234 | 63.76 (58.84–68.68) | 1.67 (1.24–2.24) | 0.001 | 1.68 (1.25–2.26) | 0.001 |
 65–80 | 352 | 276 | 78.41 (74.11–82.71) | 3.44 (2.49–4.76) | < 0.001 | 3.43 (2.47–4.76) | < 0.001 |
State/territory |  |  |  |  | < 0.001 |  | < 0.001 |
 New South Wales | 323 | 199 | 61.61 (56.31–66.91) | 1.45 (1.05–2.0) | 0.024 | 1.38 (1.0–1.91) | 0.052 |
 Northern Territory | 293 | 154 | 52.56 (46.84–58.28) | a | – | a | – |
 Queensland | 323 | 186 | 57.59 (52.20–62.97) | 1.23 (0.89–1.69) | 0.211 | 1.16 (0.84–1.60) | 0.376 |
 South Australia | 321 | 202 | 62.93 (57.64–68.21) | 1.53 (1.11–2.16) | 0.009 | 1.46 (1.05–2.03) | 0.023 |
 Tasmania | 320 | 230 | 71.88 (66.95–76.80) | 2.31 (1.65–3.22) | < 0.001 | 2.22 (1.58–3.12) | < 0.001 |
 Victoria | 317 | 213 | 67.19 (62.02–72.36) | 1.85 (1.33–2.57) | < 0.001 | 1.77 (1.27–2.47) | 0.001 |
 Western Australia | 324 | 176 | 54.32 (48.90–59.75) | 1.07 (0.78–1.48) | 0.661 | 1.01 (0.73–1.39) | 0.951 |